Cory M. Johannessen, Ph.D.
Affiliations: | 2008 | Harvard University, Cambridge, MA, United States |
Area:
GeneticsGoogle:
"Cory Johannessen"Parents
Sign in to add mentorKaren M. Cichowski | grad student | 2008 | Harvard | |
(Exploiting neurofibromatosis type 1-associated cancer models to identify novel therapeutic targets.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ito T, Young MJ, Li R, et al. (2021) Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers. Nature Genetics |
Howard TP, Oberlick EM, Rees MG, et al. (2020) Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Bolan PO, Zviran A, Brenan L, et al. (2019) Genotype-Fitness Maps of EGFR-Mutant Lung Adenocarcinoma Chart the Evolutionary Landscape of Resistance for Combination Therapy Optimization. Cell Systems |
Guièze R, Liu VM, Rosebrock D, et al. (2019) Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies. Cancer Cell |
Stover EH, Baco MB, Cohen O, et al. (2019) Pooled genomic screens identify anti-apoptotic genes as targetable mediators of chemotherapy resistance in ovarian cancer. Molecular Cancer Research : McR |
Togami K, Pastika T, Stephansky J, et al. (2019) DNA methyltransferase inhibition overcomes diphthamide pathway deficiencies underlying CD123-targeted treatment resistance. The Journal of Clinical Investigation |
Bandopadhayay P, Piccioni F, O'Rourke R, et al. (2019) Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma. Nature Communications. 10: 2400 |
Ghandi M, Huang FW, Jané-Valbuena J, et al. (2019) Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature |
Hayes TK, Luo F, Cohen O, et al. (2019) A functional landscape of resistance to MEK1/2 and CDK4/6 inhibition in NRAS mutant melanoma. Cancer Research |
Stover EH, Baco MB, Cohen O, et al. (2019) Abstract AP14: POOLED GENOMIC SCREENS IDENTIFY ANTI-APOPTOTIC GENES AS MEDIATORS OF CHEMOTHERAPY RESISTANCE IN OVARIAN CANCER Clinical Cancer Research. 25 |